⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15031954 | 1.00 | — | — | |
| SCHEMBL762292 | 1.00 | — | — | |
| SCHEMBL7600694 | 0.76 | TET2 (0.44) | — | |
| SCHEMBL10884197 | 0.73 | TDP1 (0.40) | — | |
| SCHEMBL12452174 | 0.73 | — | — | |
| SCHEMBL13449806 | 0.73 | — | — | |
| SCHEMBL13555632 | 0.73 | — | — | |
| SCHEMBL12158470 | 0.73 | TDP1 (0.52) | — | |
| SCHEMBL10554240 | 0.71 | SLC22A6 (0.35) | — | |
| SCHEMBL11160781 | 0.71 | SLC22A6 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230141981-A1 | NOVEL COMPOUNDS AND COMPOSITION FOR TARGETED THERAPY OF KIDNEY-ASSOCIATED CANCERS | Shanghai MICURX Pharmaceuticals Co., Ltd. (CN) | 2023-05-11 | — | — | US | disclosed |
| US-20160016116-A1 | FORWARD OSMOSIS SYSTEM USING COORDINATION COMPLEXES | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2016-01-21 | — | — | US | disclosed |
| US-9169258-B2 | Doripenem intermediate compound, preparation process therefor and use thereof, and preparation process for doripenem | SHENZHEN HAIBIN PHARMACEUTICAL CO., LTD. (CN) | 2015-10-27 | — | — | US | disclosed |
| US-9067915-B2 | Sunitinib and salts thereof and their polymorphs | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2015-06-30 | — | — | US | disclosed |
| US-20150038700-A1 | DORIPENEM INTERMEDIATE COMPOUND, PREPARATION PROCESS THEREFOR AND USE THEREOF, AND PREPARATION PROCESS FOR DORIPENEM | SHENZHEN HAIBIN PHARMACEUTICAL CO., LTD. (CN) | 2015-02-05 | — | — | US | disclosed |
| US-20130296575-A1 | SUNITINIB AND SALTS THEREOF AND THEIR POLYMORPHS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2013-11-07 | — | — | US | disclosed |
| US-20130149751-A1 | PROCESS FOR PREPARING AMINOCYCLOHEXYL ETHER COMPOUNDS | CARDIOME INTERNATIONAL SA (CH) | 2013-06-13 | — | — | US | disclosed |
| US-20130126443-A1 | CARBON SUPPORTED TETRAAMIDO MACROCYCLIC LIGAND CATALYTIC ACTIVATORS AND METHODS FOR MAKING THE SAME | CARNEGIE MELLON UNIVERSITY (US) | 2013-05-23 | — | — | US | disclosed |
| US-8216571-B2 | Fully human anti-VEGF antibodies and methods of using | SCHERING CORPORATION (US) | 2012-07-10 | — | — | US | disclosed |
| US-20110288086-A1 | POLYCYCLIC QUINAZOLINES, PREPARATION THEREOF, AND USE THEREOF | SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) | 2011-11-24 | — | — | US | disclosed |
| US-20110257237-A1 | PROCESS FOR THE PREPARATION OF CRYSTALLINE FORMS OF SUNITINIB MALATE | GENERICS [UK] LIMITED (GB) | 2011-10-20 | — | — | US | disclosed |
| US-20110118477-A1 | SUNITINIB AND SALTS THEREOF AND THEIR POLYMORPHS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2011-05-19 | — | — | US | disclosed |
| US-20110112164-A1 | NOVEL POLYMORPHS AND PROCESSES FOR THEIR PREPARATION | GENERICS (UK) LIMITED (GB) | 2011-05-12 | — | — | US | disclosed |
| US-20110097340-A1 | FULLY HUMAN ANTI-VEGF ANTIBODIES AND METHODS OF USING | XOMA TECHNOLOGY LTD. | 2011-04-28 | — | — | US | disclosed |